What is the treatment for Trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

Metronidazole 500 mg orally twice daily for 7 days is the preferred first-line treatment for trichomoniasis, demonstrating superior cure rates (90-95%) compared to single-dose therapy. 1

Primary Treatment Regimens

The CDC-recommended approach prioritizes the 7-day regimen over single-dose therapy based on recent comparative evidence:

  • Metronidazole 500 mg orally twice daily for 7 days achieves cure rates of 90-95% and is now the preferred regimen 1, 2
  • Metronidazole 2 g orally as a single dose remains an acceptable alternative with cure rates of approximately 81-90%, though slightly inferior to the 7-day regimen 3, 2, 4
  • A 2018 randomized controlled trial demonstrated significantly better efficacy with the 7-day regimen (89% cure rate) versus single-dose (81% cure rate), with relative risk of treatment failure 0.55 (p<0.0001) 4

Tinidazole 2 g orally as a single dose is an FDA-approved alternative for patients who cannot tolerate metronidazole 5

Critical Management Principles

Partner Treatment (Non-Negotiable)

  • All sexual partners must be treated simultaneously - this is mandatory, not optional 1, 3, 2, 6
  • Failure to treat partners is the single most common cause of recurrent infection 1
  • Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic 1, 3, 2

Alcohol Avoidance

  • Patients must avoid alcohol during treatment and for at least 24-48 hours after completing metronidazole therapy to prevent disulfiram-like reactions (nausea, vomiting, flushing, headache, abdominal cramps) 3, 2

Treatment Failure Algorithm

When initial therapy fails, follow this stepwise escalation:

  1. First treatment failure: Re-treat with metronidazole 500 mg twice daily for 7 days 1, 3, 2
  2. Second treatment failure: Metronidazole 2 g once daily for 3-5 days 1, 3, 2
  3. Persistent failure: Consult infectious disease specialist and consider susceptibility testing if reinfection has been excluded 3, 2

Special Populations

Pregnancy

  • Metronidazole is contraindicated in the first trimester 7
  • After the first trimester: Metronidazole 2 g orally as a single dose can be safely administered 7, 1

Breastfeeding

  • The 7-day regimen may be preferred if the patient cannot interrupt breastfeeding, as the lower daily dose results in less drug accumulation in breast milk 2

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients - no modification needed 7, 1, 3, 2

Metronidazole Allergy

  • Desensitization may be required, as nitroimidazoles (metronidazole and tinidazole) are the only effective oral drug class for trichomoniasis 3, 2

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 7, 1, 3
  • Re-evaluate only if symptoms persist, considering reinfection (most common) or resistant infection 1, 3

Critical Pitfalls to Avoid

Never Use Topical Metronidazole

  • Topical metronidazole gel has efficacy <50% for trichomoniasis and should NEVER be used 1, 3, 2
  • Topical preparations fail to achieve therapeutic levels in the urethra and perivaginal glands 1
  • The FDA has approved metronidazole gel only for bacterial vaginosis, not trichomoniasis 7, 6
  • Even high-dose intravaginal metronidazole/miconazole combinations show only 78-80% cure rates, inferior to oral therapy 8

Common Causes of Treatment Failure

  • Untreated sexual partners (most common cause) 1, 2
  • Using topical instead of oral therapy 1, 2
  • Patient non-adherence to the 7-day regimen 4
  • True metronidazole resistance (rare) 9

References

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Resistant Trichomoniasis.

Current infectious disease reports, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.